You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 1, 2024

Investigational Drug Information for Filgotinib


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for Filgotinib?

Filgotinib is an investigational drug.

There have been 34 clinical trials for Filgotinib. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2022.

The most common disease conditions in clinical trials are Arthritis, Arthritis, Rheumatoid, and Colitis, Ulcerative. The leading clinical trial sponsors are Galapagos NV, Gilead Sciences, and Leiden University Medical Center.

There are one hundred and thirty-two US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Filgotinib
TitleSponsorPhase
A Phase 3 Program Evaluating the Effect of Filgotinib in Participants With Active Axial SpondyloarthritisGalapagos NVPhase 3
Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid ArthritisGalapagos NVPhase 4
Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid ArthritisLeiden University Medical CenterPhase 4

See all Filgotinib clinical trials

Clinical Trial Summary for Filgotinib

Top disease conditions for Filgotinib
Top clinical trial sponsors for Filgotinib

See all Filgotinib clinical trials

US Patents for Filgotinib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Filgotinib ⤷  Try a Trial Methods for the treatment of HER2 amplified cancer Pharmacyclics LLC (Sunnyvale, CA) ⤷  Try a Trial
Filgotinib ⤷  Try a Trial Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections EMORY UNIVERSITY (Atlanta, GA) ⤷  Try a Trial
Filgotinib ⤷  Try a Trial Compounds CHIESI FARMACEUTICI S.P.A. (Parma, IT) ⤷  Try a Trial
Filgotinib ⤷  Try a Trial Cot modulators and methods of use thereof GILEAD SCIENCES, INC. (Foster City, CA) ⤷  Try a Trial
Filgotinib ⤷  Try a Trial Kinase inhibitors Respivert Limited (High Wycombe, Buckinghamshire, GB) Topivert Pharma Limited (London, GB) ⤷  Try a Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Filgotinib

Drugname Country Document Number Estimated Expiration Related US Patent
Filgotinib Canada CA2920534 2033-08-12 ⤷  Try a Trial
Filgotinib European Patent Office EP3033079 2033-08-12 ⤷  Try a Trial
Filgotinib Spain ES2709509 2033-08-12 ⤷  Try a Trial
Filgotinib Japan JP2016528251 2033-08-12 ⤷  Try a Trial
Filgotinib Japan JP2019031546 2033-08-12 ⤷  Try a Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.